| 21st Dec 2017 7:05 am |
RNS |
Grant of Options |
| 21st Dec 2017 7:00 am |
RNS |
Last patient completes dosing in LupuzorT Trial |
| 28th Nov 2017 12:00 pm |
RNS |
Holding(s) in Company |
| 24th Nov 2017 1:32 pm |
RNS |
Grant of Options |
| 2nd Nov 2017 7:00 am |
RNS |
Update on LupuzorT Pivotal Phase III Study |
| 16th Oct 2017 3:29 pm |
RNS |
Holding(s) in Company |
| 4th Oct 2017 7:00 am |
RNS |
Completion of Lanstead Sharing Agreement |
| 27th Sep 2017 7:00 am |
RNS |
Interim Results |
| 26th Sep 2017 7:00 am |
RNS |
Preparation of Lupuzor'sT Regulatory Submissions |
| 21st Sep 2017 7:00 am |
RNS |
Update on LupuzorT Pivotal Phase III Study |
| 19th Sep 2017 7:00 am |
RNS |
Notification of Interim Results |
| 18th Aug 2017 5:09 pm |
RNS |
AIM Rule 17 Notice |
| 12th Jul 2017 11:00 am |
RNS |
Grant of Options |
| 30th Jun 2017 12:04 pm |
RNS |
Result of AGM |
| 30th Jun 2017 7:00 am |
RNS |
Update on LupuzorT Pivotal Phase III Study |
| 7th Jun 2017 7:00 am |
RNS |
Annual Report & Notice of AGM |
| 1st Jun 2017 7:00 am |
RNS |
Final Results |
| 22nd May 2017 7:00 am |
RNS |
Notification of Full Year Results |
| 17th May 2017 7:00 am |
RNS |
Update on Lupuzor Phase III Study |
| 31st Mar 2017 10:17 am |
RNS |
New Employee Share Option Plan & Grant of Options |
| 31st Mar 2017 8:33 am |
RNS |
New Employee Share Option Plan & Grant of Options |
| 24th Mar 2017 7:00 am |
RNS |
ImmuPharma to present at Master Investor Show |
| 22nd Mar 2017 8:51 am |
RNS |
Holding(s) in Company |
| 20th Mar 2017 11:41 am |
RNS |
Holding(s) in Company |
| 20th Mar 2017 7:00 am |
RNS |
Holding(s) in Company |
| 10th Mar 2017 3:52 pm |
RNS |
£4.1 Million Fund Raise via Accelerated Bookbuild |
| 10th Mar 2017 7:00 am |
RNS |
Accelerated Bookbuild for the Issue of Equity |
| 6th Mar 2017 3:55 pm |
RNS |
Holding(s) in Company |
| 17th Feb 2017 2:04 pm |
RNS |
Holding(s) in Company |
| 25th Jan 2017 7:00 am |
RNS |
Update on Lupuzor Phase III Study |
| 24th Jan 2017 7:00 am |
RNS |
Change of Adviser |
| 29th Dec 2016 10:54 am |
RNS |
Holding(s) in Company |
| 22nd Dec 2016 7:00 am |
RNS |
Update on Lupuzor Pivotal Phase III Study |
| 16th Nov 2016 7:00 am |
RNS |
Update on Cancer Compound IPP-204106 'Nucant' |
| 9th Nov 2016 7:00 am |
RNS |
Holding(s) in Company |
| 26th Oct 2016 3:42 pm |
RNS |
Holding(s) in Company |
| 21st Oct 2016 5:13 pm |
RNS |
Close of Accelerated Bookbuild |
| 21st Oct 2016 1:33 pm |
RNS |
Proposed Accelerated Bookbuild for Vendor Placing |
| 30th Sep 2016 7:00 am |
RNS |
Half-year Report |
| 14th Sep 2016 7:00 am |
RNS |
UPDATE ON LUPUZOR'S PIVOTAL PHASE III STUDY |
